$DRRX DURECT CORP Insider Trading
Get free email notifications about insider trading in DURECT CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DURECT CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in DURECT CORP for free.
CIK Number: 0001082038
IRS Number: 943297098
Industry: PHARMACEUTICAL PREPARATIONS 
Trading Symbol: DRRX
Company Address: 10260 BUBB ROAD CUPERTINO 95014
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Market Capitalization: $139.97M
Prev close: $1.03
Average Daily Volume: 554,829
Days Low: $0.98
Year Low: $0.98
Year High: $2.00
DURECT CORP Latest Insider Transactions
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|Jun 16 2021||DRRX||DURECT CORP||BENITO SIMON X||Director||Option Exercise||A||1.66||55,000||91,300||55,000|
|May 17 2021||DRRX||DURECT CORP||Joice Judy R||Sr. VP Operations & ...||Option Exercise||M||0.78||40,137||31,307||0|
|May 17 2021||DRRX||DURECT CORP||Joice Judy R||Sr. VP Operations & ...||Option Exercise||M||0.73||20,000||14,600||0|
|May 17 2021||DRRX||DURECT CORP||Joice Judy R||Sr. VP Operations & ...||Sell||S||1.72||60,137||103,682||34,832||95 K to 34.8 K (-63.32 %)|
|May 17 2021||DRRX||DURECT CORP||Joice Judy R||Sr. VP Operations & ...||Buy||M||0.78||40,137||31,307||94,969||54.8 K to 95 K (+73.20 %)|
|May 17 2021||DRRX||DURECT CORP||Joice Judy R||Sr. VP Operations & ...||Buy||M||0.73||20,000||14,600||54,832||34.8 K to 54.8 K (+57.42 %)|
|Jan 19 2021||DRRX||DURECT CORP||Sussman Norman||Chief Medical Offic ...||Option Exercise||A||2.03||100,000||203,000||100,000|
|Jan 19 2021||DRRX||DURECT CORP||Joice Judy R||Sr. VP Operations & ...||Option Exercise||A||2.03||79,000||160,370||79,000|
|Jan 19 2021||DRRX||DURECT CORP||BROWN JAMES E||President & CEO||Option Exercise||A||2.03||209,000||424,270||209,000|
|Jan 19 2021||DRRX||DURECT CORP||Arenberg Michael||Chief Financial Off ...||Option Exercise||A||2.03||116,000||235,480||116,000|
|Jan 05 2021||DRRX||DURECT CORP||AZAB MOHAMMAD||Director||Option Exercise||A||2.10||70,000||147,000||70,000|
|Nov 04 2020||DRRX||DURECT CORP||Sussman Norman||Chief Medical Offic ...||Option Exercise||A||1.77||200,000||354,000||200,000|
|Sep 02 2020||DRRX||DURECT CORP||Bleichroeder LP||10% Owner||Sell||S||1.68||250,000||420,000||26,414,656||26.7 M to 26.4 M (-0.94 %)|
|Jun 19 2020||DRRX||DURECT CORP||Robertson Judith J.||Director||Option Exercise||A||2.33||55,000||128,150||55,000|
|Jun 18 2020||DRRX||DURECT CORP||HOFFMANN DAVE||Director||Option Exercise||A||2.33||55,000||128,150||55,000|